These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 3753057)

  • 1. Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection.
    Lotze MT; Carrasquillo JA; Weinstein JN; Bryant GJ; Perentesis P; Reynolds JC; Matis LA; Eger RR; Keenan AM; Hellström I
    Ann Surg; 1986 Sep; 204(3):223-35. PubMed ID: 3753057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoscintigraphy in melanoma: initial evaluation of a low protein dose monoclonal antibody cocktail.
    Wahl RL; Liebert M; Headington J; Wilson BS; Shulkin BL; Johnson JW; Mallette S; Natale RB; Coon W; East M
    Cancer Res; 1990 Feb; 50(3 Suppl):941s-948s. PubMed ID: 2297746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.
    Larson SM; Carrasquillo JA; Krohn KA; Brown JP; McGuffin RW; Ferens JM; Graham MM; Hill LD; Beaumier PL; Hellström KE
    J Clin Invest; 1983 Dec; 72(6):2101-14. PubMed ID: 6196380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.
    Buraggi GL; Callegaro L; Mariani G; Turrin A; Cascinelli N; Attili A; Bombardieri E; Terno G; Plassio G; Dovis M
    Cancer Res; 1985 Jul; 45(7):3378-87. PubMed ID: 4005860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary studies of monoclonal antibody lymphoscintigraphy in malignant melanoma.
    Nelp WB; Eary JF; Jones RF; Hellstrom KE; Hellstrom I; Beaumier PL; Krohn KA
    J Nucl Med; 1987 Jan; 28(1):34-41. PubMed ID: 3794810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
    Murray JL; Rosenblum MG; Lamki L; Glenn HJ; Krizan Z; Hersh EM; Plager CE; Bartholomew RM; Unger MW; Carlo DJ
    J Nucl Med; 1987 Jan; 28(1):25-33. PubMed ID: 3794809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved immunoscintigraphy by subcutaneous injection of 99mTc or 111In labelled F(ab')2 fragments of an anti-melanoma monoclonal antibody.
    Paganelli G; Riva P; Moscatelli G; Stacchiotti A; Agostini M; Landi G; Tison V; Pancea P; Siccardi AG
    Int J Rad Appl Instrum B; 1986; 13(4):423-8. PubMed ID: 3793497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen.
    Murray JL; Rosenblum MG; Lamki L; Haynie TP; Glenn HJ; Plager CE; Unger MW; Carlo DJ; Hersh EM
    NCI Monogr; 1987; (3):3-9. PubMed ID: 3821916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
    Temponi M; Gold AM; Ferrone S
    Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
    J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimaging of melanoma using 99mTc-labeled Fab fragment reactive with a high molecular weight melanoma antigen.
    Lamki LM; Zukiwski AA; Shanken LJ; Legha SS; Benjamin RS; Plager CE; Salk DF; Schroff RW; Murray JL
    Cancer Res; 1990 Feb; 50(3 Suppl):904s-908s. PubMed ID: 2297740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of I-131 labeled, murine Fab against a high molecular weight antigen of human melanoma: preliminary experience.
    Larson SM; Carrasquillo JA; McGuffin RW; Krohn KA; Ferens JM; Hill LD; Beaumier PL; Reynolds JC; Hellström KE; Hellström I
    Radiology; 1985 May; 155(2):487-92. PubMed ID: 3983400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma.
    Siccardi AG; Buraggi GL; Callegaro L; Mariani G; Natali PG; Abbati A; Bestagno M; Caputo V; Mansi L; Masi R
    Cancer Res; 1986 Sep; 46(9):4817-22. PubMed ID: 3731128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunospecific saturable clearance mechanisms for indium-111-labeled anti-melanoma monoclonal antibody 96.5 in humans.
    Murray JL; Lamki LM; Shanken LJ; Blake ME; Plager CE; Benjamin RS; Schweighardt S; Unger MW; Rosenblum MG
    Cancer Res; 1988 Aug; 48(15):4417-22. PubMed ID: 3390837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: a preliminary report.
    Halpern SE; Dillman RO; Witztum KF; Shega JF; Hagan PL; Burrows WM; Dillman JB; Clutter ML; Sobol RE; Frincke JM
    Radiology; 1985 May; 155(2):493-9. PubMed ID: 3983401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
    Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S
    J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 1 immunolymphoscintigraphy with an In-111-labeled antimelanoma monoclonal antibody.
    Engelstad BL; Spitler LE; Del Rio MJ; Ramos EC; Rosendorf LL; Reinhold CE; Khentigan A; Huberty JP; Corpuz SW; Lee HM
    Radiology; 1986 Nov; 161(2):419-22. PubMed ID: 3763912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved delivery of radiolabeled anti-B1 monoclonal antibody to Raji lymphoma xenografts by predosing with unlabeled anti-B1 monoclonal antibody.
    Buchsbaum DJ; Wahl RL; Glenn SD; Normolle DP; Kaminski MS
    Cancer Res; 1992 Feb; 52(3):637-42. PubMed ID: 1732052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between 131I and 111In as radiolabels for monoclonal antibodies in immunoscintigraphy of tumor bearing nude mice.
    Thedrez P; Blottiere H; Chatal JF; Grzyb J; Douillard JY
    Tumour Biol; 1986; 7(2-3):137-45. PubMed ID: 3797961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
    Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
    Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.